US-based medical diagnostics technology developer Click Diagnostics has received $70m in funding from investors including healthcare provider Cedars-Sinai Medical Center, Calcalist reported on Sunday.
Cedars-Sinai co-led the round with venture capital fund Pitango Venture Capital and John Doerr, chairman of VC firm Kleiner Perkins.
Click is still in stealth mode but is working on technology that will facilitate molecular biology and polymerase chain reaction analysis outside of dedicated laboratories. The system would allow advanced testing to take place in medical clinics and eventually at home.
The company announced in May 2019 that it had closed its series C round, a round sized at approximately $101m according to a regulatory filing submitted around the same time.
Previous filings indicate Click raised $16m in 2015 and a further $9.5m in debt financing in January 2018. Although it has not disclosed firm details concerning earlier investors, VC fund Artiman Ventures names it as a portfolio company on its website.
